Fosun International (656) H2 2024 earnings summary

Executive summary

• Total revenue for 2024 was RMB 192.14 billion, remaining stable year-over-year, with an 11-year CAGR of 13%.

• Overseas revenue grew 6.2% year-over-year to RMB 94.78 billion, accounting for 49.3% of total revenue.

• Adjusted net profit attributable to owners was RMB 750 million, excluding a one-off non-cash Cainiao impairment; reported net loss was RMB 4.35 billion.

• Strategic focus on asset-light operations, global expansion, and divestment of non-core assets, with RMB 17.5 billion in signed asset divestments.

• Four core subsidiaries contributed 70% of total revenue, with mixed performance across units.

Financial highlights

• Revenue by segment: Health RMB 46.55bn (+0.5%), Happiness RMB 76.71bn (-13.8%), Wealth RMB 55.11bn (+6.4%), Intelligent Manufacturing RMB 15.59bn (+22.2%).

• Net loss attributable to owners of the parent: RMB 4.35bn, mainly due to a one-off Cainiao impairment.

• Accumulated dividend payments reached HKD 25.7 billion over 17 years, with a payout ratio above 20% for five years.

• Investment in technology and innovation totaled RMB 6.9 billion, focusing on R&D efficiency and new AI initiatives.

• Adjusted NAV per share was HKD 17.6, far exceeding the share price.

Outlook and guidance

• Aims to reduce interest-bearing debt to approximately RMB 60 billion and maintain prudent financial management.

• Targets industrial operation profit above RMB 10 billion and continued increase in dividend payout ratio.

• Maintains goal of achieving investment-grade credit rating.

• Focus on core industries, globalization, and innovation, with signs of market recovery in tourism and consumer products.